Main Article Content
Background: Lung malignancy is a lung disease that has the highest mortality rate in the world. An examination to determine the state of lung function is spirometry.
Aim: This study aims to determine the distribution of lung function in patients with suspect of lung and mediastinal tumor at Saiful Anwar Hospital Malang based on age, sex, body mass index (BMI), and diagnosis.
Methods: This research is a descriptive analytic, cross-sectional approach using medical record data from January 2018 to December 2019 and then the data would be processed by spearman test.
Results: The results showed that patients with suspect lung and mediastinal tumors suffered the most in the age range of 51-60 years, the sexes were mostly male, the most diagnoses were lung tumors. Most of the interpretation results of the spirometry examination showed restriction, and normal body mass index. The results of the analysis of the relationship between pulmonary function descriptions had a p-value of 0.814 for diagnosis of suspected lung and mediastinal tumor, 0.003 for gender, and 0.360 for BMI.
Conclusion: It can be concluded that there is a significant relationship between pulmonary function and gender and there is no significant relationship between pulmonary function with the diagnosis and BMI.
This work is licensed under a Creative Commons Attribution 4.0 International License.
2. Sinha T. Tumors: Benign and Malignant. Canc Ther Oncol Int J. 2018;10(3):555790.
3. RI K. Pedoman Nasional Pelayanan Kedok-teran Kanker Paru. 2017.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
5. Mustafa M, Azizi AJ, IIIzam E, Nazirah A, Sharifa S, Abbas S. Lung Cancer: Risk Fac-tors, Management, And Prognosis. IOSR J Dent Med Sci. 2016;15(10):94–101.
6. Latimer KM, Mott TF. Lung cancer: diagnosis, treatment principles, and screening. Am Fam Physician. 2015 Feb;91(4):250–6.
7. Carter BW, Tomiyama N, Bhora FY, Rosado de Christenson ML, Nakajima J, Boiselle PM, et al. A modern definition of mediastinal compartments. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2014 Sep;9(9 Suppl 2):S97-101.
8. Amin Z. Characteristics of Mediastinal Tumor Patients in Cipto Mangunkusumo National Hospital Jakarta. Artik Penelit Indones J Can-cer. 2013;7(2):69–72.
9. Hardinur NIA, Ellyanti A, Rofinda ZD. Karak-teristik Penderita Tumor Mediastinum di RSUP Dr. M. Djamil, Padang periode 2015-2019. JIKESI. 2020;1(2):76–81.
10. Chairudin MR, Marhana IA, Erawati D. Profil Pasien Kanker Paru Primer yang Dirawat In-ap dan Rawat Jalan di Rumah Sakit Umum Daerah Dr Soetomo Surabaya : [Profile of Primary Lung Cancer Patients in Dr. Soetomo General Hospital Surabaya]. J Respirasi [In-ternet]. 2019;5(3):65–71. Available from: https://e-journal.unair.ac.id/JR/article/view/16086
11. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and preven-tion. Clin Chest Med. 2011 Dec;32(4):605–44.
12. Venuta F, Diso D, Onorati I, Anile M, Manto-vani S, Rendina EA. Lung cancer in elderly patients. J Thorac Dis. 2016 Nov;8(Suppl 11):S908–14.
13. Yan X, Tian X, Wu Z, Han W. Impact of Age on the Efficacy of Immune Checkpoint Inhib-itor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Vol. 10, Frontiers in on-cology. 2020. p. 1671.
14. Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, et al. A consensus statement on the gender perspective in lung cancer. Clin Transl Oncol Off Publ Fed Spanish Oncol Soc Natl Cancer Inst Mex. 2017 May;19(5):527–35.
15. of Medicine I. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products [Internet]. Bonnie RJ, Stratton K, Kwan LY, editors. Washington, DC: The National Academies Press; 2015. Available from: https://nap.nationalacademies.org/catalog/18997/public-health-implications-of-raising-the-minimum-age-of-legal-access-to-tobacco-products
16. Sanikini H, Yuan J-M, Butler LM, Koh W-P, Gao Y-T, Steffen A, et al. Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four co-hort studies. BMC Cancer. 2018 Feb;18(1):220.
17. Lenoir A, Fitting J-W, Marques-Vidal P-M, Vollenweider P, Nicod LP. GLI 2012 equa-tions define few spirometric anomalies in the general population: the PneumoLaus study. Respir Res. 2018 Dec;19(1):250.
18. Kachuri L, Johansson M, Rashkin SR, Graff RE, Bossé Y, Manem V, et al. Immune-mediated genetic pathways resulting in pul-monary function impairment increase lung cancer susceptibility. Nat Commun [Inter-net]. 2020;11(1):27. Available from: https://doi.org/10.1038/s41467-019-13855-2
19. Verma A, Goh SK, Tai DYH, Kor AC, Soo CI, Seow DGF, et al. Outcome of advanced lung cancer with central airway obstruction <em>versus</em> without central airway obstruction. ERJ Open Res [Internet]. 2018 Apr 1;4(2):173–2017. Available from: http://openres.ersjournals.com/content/4/2/00173-2017.abstract
20. Stone E, Slatore CG. The Obesity Paradox—What Does It Mean for Lung Cancer Surgery? J Thorac Oncol [Internet]. 2017;12(8):1174–6. Available from: https://www.sciencedirect.com/science/article/pii/S1556086417304641
21. Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complica-tions, biochemical abnormalities, and im-pairment of lung function. Multidiscip Respir Med [Internet]. 2016;11(1):28. Available from: https://doi.org/10.1186/s40248-016-0066-z